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PaaX is the main regulator of the phenylacetic acid aerobic degradation pathway
in bacteria and acts as a transcriptional repressor in the absence of its inducer
phenylacetyl-coenzyme A. The natural presence and the recent accumulation
of a variety of highly toxic aromatic compounds owing to human pollution has
created considerable interest in the study of degradation pathways in bacteria,
the most important microorganisms capable of recycling these compounds,
in order to design and apply novel bioremediation strategies. PaaX from
Escherichia coliWwas cloned, overexpressed, purified and crystallized using the
sitting-drop vapour-diffusion method at 291 K. Crystals grew from a mixture of
0.9M Li2SO4 and 0.5M sodium citrate pH 5.8. These crystals, which belonged to
the monoclinic space group C2 with unit-cell parameters a = 167.88, b = 106.23,
c = 85.87 A˚,  = 108.33, allowed the collection of an X-ray data set to 2.3 A˚
resolution.
1. Introduction
After carbohydrates, aromatic compounds are the most abundant
class of organic compounds used by nature (Harwood & Parales,
1996) and their concentrations have recently increased in many
ecosystems as a consequence of human pollution (OECD, 1994).
Microorganisms, mostly bacteria, recycle both natural and man-made
aromatic compounds. In this sense, the degradation pathways used
by these microorganisms are highly relevant in the field of bio-
remediation, which uses microorganisms or their enzymes to elim-
inate pollutants from contaminated environments (Ramos et al., 1994;
Harwood & Parales, 1996; Pieper & Reineke, 2000).
In bacteria, aerobic degradation of phenylacetic acid (PAA) begins
with the esterification of PAA with coenzyme A (CoA) by phenyl-
acetyl-CoA (PA-CoA) ligase, which is common to anaerobic degra-
dation pathways (Luengo et al., 2001), in contrast to the degradation
of hydroxylated PAA derivatives. In Escherichia coli W, paa gene
clusters code for enzymes that aerobically degrade PAA (Ferra´ndez
et al., 1998). Homologues of paa genes have been found in different
microorganisms, all of which have similar regulation mechanisms
(Garcı´a et al., 2000; Rost et al., 2002; Navarro-Llorens et al., 2005; del
Peso-Santos et al., 2006; Di Gennaro et al., 2007).
The transcriptional repressor PaaX (315 amino acids, 35 295 Da;
Ferra´ndez et al., 1998) encoded in one of the paa clusters represses
the expression of the PAA aerobic degradation pathway enzymes,
binding to the operator sequences in the paa gene clusters in the
absence of PA-CoA and therefore blocking transcription by RNA
polymerase. When the PA-CoA concentration increases the repressor
is released from the DNA, allowing transcription to proceed. Addi-
tionally, PaaX regulates the expression of degradation pathways that
produce PAA as their final product, such as penicillin G acylase
(PGA), which hydrolyses numerous esters and amines of phenyl-
acetic acid (Gala´n et al., 2004; Kim et al., 2004), and the styrene-
degradation pathway in Pseudomonas sp. strain Y2 (del Peso-Santos
et al., 2006). Hence, PaaX is currently considered to be a central
regulator in the aerobic degradation of aromatic compounds derived
from PAA in several microorganisms (Luengo et al., 2001).
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PaaX is classified in the Pfam database as a member of the PaaX-
like protein family (http://pfam.sanger.ac.uk/family/PF07848), which
encompasses transcriptional regulators of the PAA-degradation
pathway in several proteobacteria. The N-terminal region of PaaX-
like proteins has sequence homology to the winged helix–turn–helix
(wHTH) motif of the GntR family of transcriptional regulators, while
the C-terminal region bears no homology to other protein families
(Ferra´ndez et al., 2000; Tropel & van der Meer, 2004). Therefore, it
has been speculated that PaaX comprises two domains, with the
N-terminal domain being in charge of binding DNA and repressing
transcription, while the C-terminal domain binds the PA-CoA acti-
vator and regulates the activity of the N-terminal domain (Ferra´ndez
et al., 2000). Interestingly, the proposed palindromic consensus DNA-
binding sequence of PaaX has a separation of 25 bp between the two
halves of the palindrome (Kim et al., 2004), which is unprecedented in
transcriptional regulators of the GntR family.
Although the function of PaaX has been thoroughly studied,
structural studies are absent from the literature. Only two structures
from the PaaX-like protein family have been deposited in the PDB
(PDB entries 3l09 from Jannaschia sp. and 3kfw fromMycobacterium
tuberculosis; Joint Center for Structural Genomics, unpublished work;
U. A. Ramagopal, R. Toro, S. K. Burley & S. C. Almo, unpublished
work) and preliminary crystallization and X-ray analyses have been
reported for a PaaX-like protein (Cao et al., 2009). However, no
further analysis of these structures has been published.
In this work, we report the crystallization and preliminary X-ray
diffraction studies of a cysteine-lacking variant of PaaX from
E. coli W.
2. Experimental
2.1. E. coli PaaX expression and purification
A hexahistidine-tagged cysteine-lacking variant of PaaX, HisPaaX
C4, was purified from pX2BSc0 plasmid in E. coli MV1184 cells
(Sambrook & Russell, 2001). This mutant conserves its DNA-binding
and transcription-activation functionality, as well as the overall
structure and stability of the wild-type form (Herna´ndez-Rocamora
et al., unpublished results). A fresh transformant colony was grown
overnight at 310 K. The culture was diluted 100-fold in 1 l LB
medium and grown at 303 K until the optical density at 600 nm
reached 0.5–0.6. Overexpression was induced by the addition of
isopropyl -d-1-thiogalactopyranoside (IPTG) to a concentration of
1 mM followed by further incubation at 303 K for 16 h.
Cultures were harvested by centrifugation at 3000g for 15 min at
277 K. The cells were resuspended in 40 ml Im20 buffer (50 mM
sodium phosphate pH 8 with 300 mM NaCl and 20 mM imidazole)
and sonicated on ice in a Branson 250 sonicator. The soluble protein
fraction was separated by centrifugation at 100 000g for 1 h at 277 K.
Supernatants were mixed in batches with 5 ml chelating Sepharose
(Chelating Sepharose Fast Flow, GE Healthcare) loaded with Ni and
gently stirred for 1 h at room temperature (RT). The Sepharose with
the absorbed protein was packed into a column and washed conse-
cutively with two column volumes of Im20 buffer and two column
volumes of Im100 buffer (as Im20 but with 40 mM imidazole). PaaX
was eluted with Im400 buffer (20 mM Tris–HCl pH 8 with 500 mM
NaCl and 400 mM imidazole). The fractions containing the highest
concentrations of PaaX (measured using UV absorbance; the purity
was checked by SDS–PAGE) were pooled. Samples were frozen
quickly in a dry-ice/ethanol bath and stored at 193 K.
2.2. Crystallization
Initial crystallization assays based on the commercial screens
JCSG+ Suite and PACT Suite from Qiagen and Crystal Screen and
Crystal Screen 2 from Hampton Research were carried out by high-
throughput techniques using a NanoDrop ExtY robot (Innovadyne
Technologies Inc.). All crystallization trials were performed by the
sitting-drop vapour-diffusion method at 291 K in Innovaplate SD-2
microplates (Innovadyne Technologies Inc.), mixing equal amounts
(250 nl) of PaaX solution at 9.7 mg ml1 [20 mM Tris pH 8, 500 mM
NaCl, 400 mM imidazole and 20%(v/v) glycerol] and precipitant
solution. The drops (500 nl) were equilibrated against 65 ml precipi-
tant solution. Optimized crystals were obtained by scaling up the
drop volume using the sitting-drop method: 1 ml PaaX solution was
mixed with 1 ml precipitant solution and equilibrated against 500 ml
precipitant solution.
2.3. Diffraction data collection and processing
Crystals were soaked for 5 s in a cryoprotectant solution [20%(v/v)
glycerol in the crystallization mother liquor] prior to flash-cooling at
100 K by direct transfer into liquid nitrogen using a cryogenic system.
X-ray data sets were collected using synchrotron radiation at the
ESRF, Grenoble, France. A data set was collected from a PaaX
crystallization communications
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Table 1
Data-collection statistics for PaaX crystals.
Values in parentheses are for the highest resolution shell.
Crystal data
Space group C2
Unit-cell parameters
a (A˚) 167.88
b (A˚) 106.23
c (A˚) 85.87
 () 108.33
Data processing
Temperature (K) 100
Wavelength (A˚) 0.9334
Resolution (A˚) 44.2–2.3 (2.4–2.3)
Unique data 63547
Multiplicity 3.7 (3.7)
Data completeness (%) 99.9 (99.9)
Average I/(I) 20.9 (2.8)
Molecules in asymmetric unit 4
Matthews coefficient (A˚3 Da1) 2.89
Solvent content (%) 61
Rmerge† 0.05 (0.49)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith measure-
ment of reflection hkl and hI(hkl)i is the weighted mean of all measurements.
Figure 1
PaaX crystals obtained with 0.9M lithium sulfate and 0.5M sodium citrate pH 5.8
under polarized light. The approximate dimensions of the crystals are 0.15  0.4 
0.4 mm.
crystal to 2.3 A˚ resolution on beamline ID14-1 ( = 0.93340 A˚) using
an ADSC Quantum Q210 detector (oscillation range 1, crystal-to-
detector distance 191.64 mm). The diffraction data were processed
using the XDS program (Kabsch, 2010) and scaled using SCALA
(Evans, 1993) from the CCP4 program suite (Winn et al., 2011);
processing data are summarized in Table 1.
3. Results
A fully functional PaaX variant containing an N-terminal hexahisti-
dine tag and with all four cysteine residues present in the wild-type
protein substituted by alanines was constructed (Herna´ndez-
Rocamora et al., unpublished results) in order to increase the stability
during purification and to avoid aggregation at the concentrations
required for crystallization purposes.
PaaX microcrystals grew from condition No. 15 of Crystal Screen 2
(1.0M lithium sulfate, 0.5M ammonium sulfate and 0.5M sodium
citrate pH 5.6). Good-quality crystals of PaaX were obtained from
optimized conditions (0.9M lithium sulfate and 0.5M sodium citrate
pH 5.8; Fig. 1). An X-ray data set was collected to 2.3 A˚ resolution.
The images displayed good-quality diffraction patterns (Fig. 2).
Preliminary X-ray data processing showed good statistics (Table 1).
The crystal belonged to the monoclinic space group C2, with unit-cell
parameters a = 167.88, b = 106.23, c = 85.87 A˚,  = 108.33. Specific
volume calculations based on the molecular weight of PaaX (32 kDa)
and the unit-cell parameters (volume = 1 458 706.8 A˚3) indicated the
possible presence of four monomer molecules in the asymmetric unit
with 61% solvent content (VM = 2.89 A˚
3 Da1; Matthews, 1968).
Structural determination of PaaX by the molecular-replacement
method using the structural model from Jannaschia sp. (PDB entry
3l09; Joint Center for Structural Genomics, unpublished work), which
shows 30% sequence homology, is currently in progress.
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Figure 2
(a) X-ray diffraction pattern of PaaX crystals; (b) an enlargement showing high-resolution spots.
